Changing Lives Together: Through 80 Years of Research

Total Page:16

File Type:pdf, Size:1020Kb

Changing Lives Together: Through 80 Years of Research For a world where diabetes can do no harm Get in touch 0345 123 2399* [email protected] @DiabetesUK www.diabetes.org.uk www.diabetes.org.uk/forum *Monday–Friday, 9am–6pm. The cost of calling 0345 numbers can vary according to the provider. Changing lives together: Calls may be recorded for quality and training purposes. through 80 years of research 1st edition – March 2018 © Diabetes UK 2018. 1331. A charity registered in England and Wales (no. 215199) and in Scotland (no. SC039136). Join us on this remarkable journey 3 We’re stopping the harm diabetes causes 4 We’ve changed the way Type 2 diabetes is treated 6 We’ve tackled blindness 8 We’re stopping heart attacks and strokes 10 We’ve prevented amputations 12 We’ve made living with diabetes easier 14 We funded the first insulin pen 16 We’re helping people manage their Type 1 diabetes 18 We’ve made blood glucose checking simple 20 We’re making the artificial pancreas a reality 22 We’re taking big steps towards ending diabetes 24 We’re helping people with Type 1 diabetes produce their own insulin 26 Join us on this We’re stopping Type 1 diabetes in its tracks 28 remarkable journey We’re putting Type 2 diabetes into remission 30 We’re building our knowledge of diabetes 32 Diabetes UK has an incredible legacy in diabetes research, We’re getting diagnosis and treatment right 34 funding scientists across the UK for over 80 years. We’re building a clearer picture of diabetes 36 This has only been possible thanks to our researchers who led the way and from some of supporters. Together, we’ve funded some of the the people whose lives have been changed. We’re discovering more about rare types of diabetes 38 greatest transformations in diabetes care. We know this report only scratches the surface Stepping into the future 40 The scale of diabetes is vast. More than of the difference our researchers have made to 4.6 million people live with the condition in the lives of people with diabetes. And we look Our support in numbers 42 the UK. We need urgent action to make sure forward to sharing more stories with you in Help us build a world where diabetes can do no harm 44 everyone gets the treatment they need. We the future. have been rising to this challenge for decades. Thank you 46 And with more lives to change than ever before It’s time to celebrate the fantastic innovations we cannot stop now. This is a celebration, but in research we’ve been behind and the exciting References 47 it’s also a rallying call. We have more research steps that lie ahead. to do and more lives to improve. You have helped us transform the lives of Your continued support will help us to keep millions of people with diabetes. When you breaking new ground for people with diabetes. read this report you will realise that our research has, in some way, touched the lives of almost Thank you for being part of our fight for a world everyone with diabetes in the UK. We couldn’t where diabetes can do no harm. have done it without you. Dr Elizabeth Robertson, So join us as we take a journey through Director of Research 80 years of achievements. Hear from the 2 | Changing lives together Changing lives together | 3 We’re stopping the harm diabetes causes Diabetes is devastating lives every day. Our research finds way to reduce that harm. Back in 1964 Professor Harry Keen led the way by developing a way to screen and monitor kidney disease with our funding [1]. His pioneering Bedford Study found 250 people with undiagnosed Type 2 diabetes and helped him to develop the term ‘borderline diabetes’ to describe people at very high risk of the condition. Since then, from small local studies to huge national trials, our research has been at the forefront of the fight against diabetes complications. What our scientists have discovered has changed the way diabetes is treated, benefitting millions of people. Not just here in the UK, but across the world. To recognise Professor Harry Keen’s contribution to diabetes research and care, we established the Harry Keen Intermediate Clinical Fellowship in his honour. 4 | Changing lives together Changing lives together | 5 1977 1997 We’ve changed Who, where and when Name: UK Prospective Diabetes the way Type 2 Study (UKPDS) diabetes is Research Professors Robert Turner treated leaders: and Rury Holman Where: University of Oxford When: 1977–1997 Impact: Improved blood glucose and blood pressure control linked to reduced complications Sometimes it’s hard to believe how much progress we've made in our understanding of diabetes. The UK Prospective Diabetes Study, known as At the end of the trial, the overall risk of UKPDS, is a good example. complications affecting small blood vessels More than 5,000 people with Type 2 diabetes dropped by a quarter. Over 30 years on, follow- took part in the research which showed that up results showed a positive impact on the risk improved blood glucose and blood pressure of eye and kidney complications, heart attacks [3] levels could help reduce complications [2]. and death . We take that knowledge for granted now. With more than 4.6 million people living with diabetes in the UK, and hundreds of million But at the time the enormity of this 20-year trial more worldwide, this piece of work has “These findings have had a profound influence was shown by the thousands of people who played a significant role in reducing the harm on the management of Type 2 diabetes, clinical tuned in from all over the world to hear the diabetes does. guidelines, and standards of care, and have results. And the collective roar which greeted helped reduce the risk of diabetes-related the findings. It was made possible by Diabetes UK complications worldwide.” supporters who donated £640,000 after we The research changed treatment and care for launched an appeal to fund the completion of Professor Rury Holman, people all over the world and it’s recognised the first 13 years of the trial in 1990. Co-Director of UKPDS, University of Oxford as a major step forward in understanding how best to manage Type 2 diabetes. 6 | Changing lives together Changing lives together | 7 1986 2010 We’ve tackled Who, where and when Name: Detecting diabetic blindness retinopathy Research Professor Roy Taylor leader: Where: Newcastle University When: 1986 – 2010 Impact: Led to a nationwide screening programme reducing sight loss Diabetes was once the leading cause of blindness in the UK amongst people of working age. It isn’t any more. And that’s thanks to a piece of research we funded in the 1980s. Shocked by the amount of sight loss in people So Professor Taylor expanded his fleet of with diabetes in Newcastle, Professor Roy mobile screening units across the UK [4, 5]. Taylor began looking into how it could Once again the results were positive, be reduced. proving photographic screening worked on His plan to beat blindness began in the back of a large scale. a second hand ambulance in 1986. Buoyed by the evidence, we campaigned for a There he used a retinal camera to photograph national eye screening programme for people people’s eyes. His team would then analyse with diabetes, which was rolled out in 2002. the results on the spot to see if there were Today every single person with diabetes should any early signs of diabetic eye disease (known have access to annual eye screening. as retinopathy). It means better vision for people with diabetes. “Losing eyesight can be avoided if retinopathy is Being able to treat any damage early reduces In 2009, Newcastle became the first place caught early and treated. Easier, more accessible the chance of people losing any vision. in the UK where diabetes is no longer the screening methods allow us to do just that. With leading cause of blindness in the working And by making the service mobile, more the support of Diabetes UK, we’re seeing the age population [6]. That effect has now spread people could be screened and referred for impact of this work on the lives of people with across the UK. treatment if they needed it. diabetes across the world.” The results showed that this eye screening Professor Roy Taylor, method for people with diabetes was far more Newcastle University practical and effective than other methods. 8 | Changing lives together Changing lives together | 9 1999 2003 We’re stopping Who, where and when Name: Collaborative Atorvastatin heart attacks Diabetes Study (CARDS) and strokes Research Professors Helen Colhoun leaders: and John Betteridge Where: University of Edinburgh, University College London When: 1999 – 2003 Impact: Statins now used to improve health of people with Type 2 diabetes Having diabetes more than doubles someone’s risk of experiencing a heart attack, heart failure or a stroke. One in four people admitted to hospital The results were so clear that the decision was with these cardiovascular complications made to end CARDS two years early so that has diabetes. everyone on the trial could benefit from [7] In 2003, research we funded found that the drug . statins – a cholesterol-lowering drug – could Preventing one heart attack or stroke means reduce the risk of people with Type 2 diabetes that a life is saved or not turned upside down. experiencing a heart attack or stroke. A family free from the trauma of suddenly losing The nationwide trial, called CARDS (Collaborative a loved one.
Recommended publications
  • King's College Hospital Board of Directors
    King’s College Hospital Board of Directors PUBLIC AGENDA Time of meeting 14:00 Date of meeting Tuesday, 16 December 2014 Venue Dulwich Room, Hambledon Wing, Denmark Hill Members: Prof. Sir George Alberti (GA) Trust Chair Graham Meek (GM) Non-Executive Director, Vice Chair Marc Meryon (MM1) Non-Executive Director Christopher Stooke (CS) Non-Executive Director Sue Slipman (SS) Non-Executive Director Tim Smart (TS) Chief Executive Angela Huxham (AH) Director of Workforce Development Trudi Kemp (TD) - Non-voting Director Director of Strategy Dr. Michael Marrinan (MM) Medical Director Roland Sinker (RS) Chief Operating Officer Simon Taylor (ST) Chief Financial Officer Dr. Geraldine Walters (GW) Director of Nursing & Midwifery Jane Walters (JW) - Non-voting Director Director of Corporate Affairs In attendance: Tamara Cowan (TC) Board Secretary (Minutes) Prof. Sir Robert Lechler (RL) Executive Director, KHP Sally Lingard (SL) Associate Director of Communications Linda Smith KCH Charity Representative Apologies: Prof. Ghulam Mufti (GM1) Non-Executive Director Faith Boardman (FB) Non-Executive Director Circulation to: Board of Directors Circulation List Enclosure Lead Time 1. STANDING ITEMS G Alberti 14:00 1.1. Apologies 1.2. Declarations of Interest 1.3. Chair’s Action 1.4. Minutes of Previous Meeting – 25/11/2014 Enc 1.4 1.5. Matters Arising/Action Tracking Enc 1.5 2. FOR REPORT/DISCUSSION 2.1. Update from Board Committee Chairs 14:05 2.1.1. Audit Committee Verbal C Stooke 2.1.2. Board Integration Committee Verbal C Stooke 2.1.3. Finance & Performance Committee Verbal G Meek 2.1.4. Quality & Governance Committee Verbal G Alberti 2.1.5.
    [Show full text]
  • Female Fellows of the Royal Society
    Female Fellows of the Royal Society Professor Jan Anderson FRS [1996] Professor Ruth Lynden-Bell FRS [2006] Professor Judith Armitage FRS [2013] Dr Mary Lyon FRS [1973] Professor Frances Ashcroft FMedSci FRS [1999] Professor Georgina Mace CBE FRS [2002] Professor Gillian Bates FMedSci FRS [2007] Professor Trudy Mackay FRS [2006] Professor Jean Beggs CBE FRS [1998] Professor Enid MacRobbie FRS [1991] Dame Jocelyn Bell Burnell DBE FRS [2003] Dr Philippa Marrack FMedSci FRS [1997] Dame Valerie Beral DBE FMedSci FRS [2006] Professor Dusa McDuff FRS [1994] Dr Mariann Bienz FMedSci FRS [2003] Professor Angela McLean FRS [2009] Professor Elizabeth Blackburn AC FRS [1992] Professor Anne Mills FMedSci FRS [2013] Professor Andrea Brand FMedSci FRS [2010] Professor Brenda Milner CC FRS [1979] Professor Eleanor Burbidge FRS [1964] Dr Anne O'Garra FMedSci FRS [2008] Professor Eleanor Campbell FRS [2010] Dame Bridget Ogilvie AC DBE FMedSci FRS [2003] Professor Doreen Cantrell FMedSci FRS [2011] Baroness Onora O'Neill * CBE FBA FMedSci FRS [2007] Professor Lorna Casselton CBE FRS [1999] Dame Linda Partridge DBE FMedSci FRS [1996] Professor Deborah Charlesworth FRS [2005] Dr Barbara Pearse FRS [1988] Professor Jennifer Clack FRS [2009] Professor Fiona Powrie FRS [2011] Professor Nicola Clayton FRS [2010] Professor Susan Rees FRS [2002] Professor Suzanne Cory AC FRS [1992] Professor Daniela Rhodes FRS [2007] Dame Kay Davies DBE FMedSci FRS [2003] Professor Elizabeth Robertson FRS [2003] Professor Caroline Dean OBE FRS [2004] Dame Carol Robinson DBE FMedSci
    [Show full text]
  • Acute Med V10 N1.Qxd 16/02/2011 16:10 Page 3
    Acute Medicine V10 N1_Acute Med V10 N1.qxd 16/02/2011 16:10 Page 3 Acute Medicine 2011; 10(1): 3-4 3 Guest Editorial The Rebirth of General, ‘Acute’ Medicine: will the baby survive? Professor Sir George Alberti uring the 1980s and 1990s general medicine specialty. Unfortunately this was not the conclusion was progressively displaced by medical of the first working party! However, a subsequent D specialties as the major focus of a consultant group did indeed agree that the development of physician’s career. Fewer and fewer people were acute medicine was important, leading to the appointed as ‘general physicians with a specialist creation of Acute Medicine as a subspeciality of interest’, which had been the norm prior to this. GIM. Concerns were expressed that consultants Specialists whose main focus was their ‘ology’ were appointed to such posts would suffer burn-out; continuing to be expected to take their share of acute inevitably those appointed in the first waves were medical “takes”. Training for most medical also accredited in another speciality. A 4 year training specialties still encompassed training in General programme, which provided accreditation in GIM Internal Medicine (GIM). However, this often was with recognition of the subspeciality training in truncated in favour of the main specialty and was Acute Medicine was developed. Later, the even resented, by some, as interfering with their recognition of Acute Internal Medicine (AIM) as a “proper” training. None of this was surprising: speciality in its own right ensured the development medical specialties were becoming more complex & of a specific AIM curriculum with its own set of many more treatments, interventions and diagnostic competencies allowing dual accreditation with GIM.
    [Show full text]
  • Download Resource-48-Autumn-2015
    ISSUE 48 AUTUMN 2015 rThee Newslettersourc of Scotland’s Nationale Academy The RSE hosts an Awards Reception every year, at which the achievements of all of its awardees are announced and celebrated. The event took place this year on Monday 7 September. Pictured are eight of the awardees, recipients of various awards, all from the University of Aberdeen. A full list of all the awardees is on pages 12–15 and further details of the evening can be found on the back page. Also featured in this issue: Options for Scotland’s Gas Future Interview with Professor Sue Black Full list of RSE Awardees 2015 resource AUTUMN 2015 The RSE Comments Entrepreneurial Education in Scotland The Scottish Government has • Skills for growth for practitioners to oversee a declared its ambition for Scotland entrepreneurs and business comprehensive programme for to become a world-leading leaders who are ready to the delivery of entrepreneurial entrepreneurial nation. The scale up an existing venture. education in Scotland, with the Business Innovation Forum (BIF) strong endorsement and support From the outset, it was clear that of the Royal Society of Edinburgh of the Scottish Government and a joined-up approach is crucial to welcomes this vision but Scottish Funding Council. ensuring the consistency and quality recognises also that achieving In addition, the report calls on it will require a fundamental universities to consider how shift in the mind set, skills and they can best support all confidence of Scotland’s academic staff to understand current, and future, workforce. the relevance and importance Scottish universities have a of enterprise education across pivotal role to play in shaping the full curriculum, and to an innovative and dynamic develop their capacity to workforce.
    [Show full text]
  • Metabolic Syndrome
    The IDF consensus worldwide de nition of the METABOLIC SYNDROME No part of this publication may be reproduced or transmitted in any form or by any means without the prior written permission of the International Diabetes Federation (IDF). Requests to reproduce or translate IDF publications should be addressed to: IDF Communications Avenue Emile De Mot 19, B-1000 Brussels, Belgium by fax at +32-2-5385114 or by e-mail at [email protected] © International Diabetes Federation, 2006 2 The IDF worldwide defi nition of the metabolic syndrome was developed during a unique consensus workshop on the initiative of Professors Sir George Alberti and Paul Zimmet. The workshop was held on behalf of the IDF Task Force on Epidemiology and Prevention. After the meeting, a writing group was convened including: Sir George Alberti, London, UK Paul Zimmet, Melbourne, Australia Jonathan Shaw, Melbourne, Australia Scott M. Grundy, Dallas, USA, Consultant to Writing Group The IDF metabolic syndrome consensus defi nition process (workshop) was supported by an educational grant from AstraZeneca Pharmaceuticals. AstraZeneca had no role in the development of the consensus defi nition, or in the review or approval of the manuscript. This publication has been funded by IDF. The IDF also gratefully acknowledges the contribution of: Pablo Aschner - Bogotá, Columbia Beverley Balkau - France Philip Barter - Sydney, Australia Peter Bennett - Phoenix, USA Edward Boyko - Seattle, USA John Brunzell - Seattle, USA Juliana Chan - Hong Kong, SAR China Ralph DeFronzo - San Antonio,
    [Show full text]
  • Cytocensus, Mapping Cell Identity and Division in Tissues and Organs Using Machine Learning
    TOOLS AND RESOURCES CytoCensus, mapping cell identity and division in tissues and organs using machine learning Martin Hailstone1, Dominic Waithe2, Tamsin J Samuels1, Lu Yang1, Ita Costello3, Yoav Arava4, Elizabeth Robertson3, Richard M Parton1,5, Ilan Davis1,5* 1Department of Biochemistry, University of Oxford, Oxford, United Kingdom; 2Wolfson Imaging Center & MRC WIMM Centre for Computational Biology MRC Weather all Institute of Molecular Medicine University of Oxford, Oxford, United Kingdom; 3The Dunn School of Pathology,University of Oxford, Oxford, United Kingdom; 4Department of Biology, Technion - Israel Institute of Technology, Haifa, Israel; 5Micron Advanced Bioimaging Unit, Department of Biochemistry, University of Oxford, Oxford, United Kingdom Abstract A major challenge in cell and developmental biology is the automated identification and quantitation of cells in complex multilayered tissues. We developed CytoCensus: an easily deployed implementation of supervised machine learning that extends convenient 2D ‘point-and- click’ user training to 3D detection of cells in challenging datasets with ill-defined cell boundaries. In tests on such datasets, CytoCensus outperforms other freely available image analysis software in accuracy and speed of cell detection. We used CytoCensus to count stem cells and their progeny, and to quantify individual cell divisions from time-lapse movies of explanted Drosophila larval brains, comparing wild-type and mutant phenotypes. We further illustrate the general utility and future potential of CytoCensus by analysing the 3D organisation of multiple cell classes in Zebrafish retinal organoids and cell distributions in mouse embryos. CytoCensus opens the possibility of straightforward and robust automated analysis of developmental phenotypes in complex tissues. *For correspondence: [email protected] Competing interest: See Introduction page 25 Complex tissues develop through regulated proliferation and differentiation of a small number of Funding: See page 25 stem cells.
    [Show full text]
  • 1. Editorial: Les Chiens Aboient, La Caravane Passé Proverb: 1
    IAPB Africa Newsletter Volume 5, No 2, Q 2, 2016 CONTENTS 1. Editorial: Les Chiens Aboient, La Caravane Passé Proverb: 1. Editorial Life goes on, even if some will try to stop or talk against progress. 2. IAPB News Over the last 50 years, how we think about and how we approach the provision of 3. Technology eye care services in Africa has undergone several major paradigm shifts, from the 4. Disability initial prioritisation of restoration of sight, through the prevention of blindness era 5. Resources to the current paradigm of comprehensive eye health and universal coverage. 6. Knowledge Of course, everyone grows tired of hearing about „paradigm shifts‟ which nowadays 7. IAPB 10GA seem to be applied to the most mundane of changes. A paradigm shift, as identified 8. Snippets by American physicist Thomas Kuhn, is a fundamental change in the basic concepts and practices of a scientific discipline, leading to a scientific revolution when scientists encounter anomalies that cannot be explained by the current paradigm. In social sciences a paradigm shift replaces the former way of thinking or organizing with a radically different way of thinking or organizing. When enough significant anomalies have accrued against a current paradigm, the scientific discipline is thrown into a state of crisis. During this crisis, new ideas are tried. Eventually a new paradigm is formed, which gains its own new followers, and an intellectual "battle" takes place between the followers of the new paradigm and the hold-outs of the old paradigm. Africa has significantly
    [Show full text]
  • Smutty Alchemy
    University of Calgary PRISM: University of Calgary's Digital Repository Graduate Studies The Vault: Electronic Theses and Dissertations 2021-01-18 Smutty Alchemy Smith, Mallory E. Land Smith, M. E. L. (2021). Smutty Alchemy (Unpublished doctoral thesis). University of Calgary, Calgary, AB. http://hdl.handle.net/1880/113019 doctoral thesis University of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission. Downloaded from PRISM: https://prism.ucalgary.ca UNIVERSITY OF CALGARY Smutty Alchemy by Mallory E. Land Smith A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL FULFILMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY GRADUATE PROGRAM IN ENGLISH CALGARY, ALBERTA JANUARY, 2021 © Mallory E. Land Smith 2021 MELS ii Abstract Sina Queyras, in the essay “Lyric Conceptualism: A Manifesto in Progress,” describes the Lyric Conceptualist as a poet capable of recognizing the effects of disparate movements and employing a variety of lyric, conceptual, and language poetry techniques to continue to innovate in poetry without dismissing the work of other schools of poetic thought. Queyras sees the lyric conceptualist as an artistic curator who collects, modifies, selects, synthesizes, and adapts, to create verse that is both conceptual and accessible, using relevant materials and techniques from the past and present. This dissertation responds to Queyras’s idea with a collection of original poems in the lyric conceptualist mode, supported by a critical exegesis of that work.
    [Show full text]
  • 9306Tc054.Pdf
    ORDER OF EVENTS INVOCATION Eugene Samuel Ashton, University Chaplain A THEM The Star Spangled Banner ADDRESS Paul A. Freund CO 1FERRING OF HONORARY DEGREES CONFERRING OF DEGREES IN COURSE College of Liberal Arts Graduate School of Arts and Sciences Jackson College Fletcher School of Law and Diplomacy College of Engineering School of Medicine College of Special Studies School of Dental Medicine Crane Theological School AN1'HEM Dear Alma Mater, Jane Eichkern, J'71 BE EDICTION HONORARY DEGREE RECIPIENTS KENNETH B. CLARK ( L.H .D.) Psychologist. President of the Metropol itan Applied Research Center, Inc., and professor of psychology, City College of the City University of New York; member, New York State Board of Regents. B.A. and M.A., Howard University, 1935 and 1936; Ph.D., Columbia University, 1940. A member of Phi Beta Kappa and Sigma Xi, he holds four honorary degrees. He has taught at Howard University, Hampton Institute, Queens College, and has been a visiting professor at Columbia University, the University of California at Berkeley, and Harvard University. Formerly president of the Society for the Psychological Study of Social Issues and board member of the American Psychological Association. he is a trustee of Howard University and of Antioch College. He received the Spingarn Medal from the NAACP in I 961, and the Kurt Lewin Memorial Award in 1966. He was appointed by President Lyndon B. Johnson to the Council for the Humanities in 1966. One of his several books, Dark Ghello: Dilemmas of Social Power, received the Sidney Hillman Prize, and his work on the effect of segrega ti on on children was cited by the U.S.
    [Show full text]
  • King's College Hospital Board of Directors
    King’s College Hospital Board of Directors PUBLIC AGENDA Time of meeting 14:00 - 16:00 Date of meeting Tuesday, 25 March 2014 Venue Boardroom, Trust Headquarter, PRUH Members: Prof. Sir George Alberti (GA) Trust Chair Graham Meek (GM) Non-Executive Director, Vice Chair Faith Boardman (FB) Non-Executive Director Marc Meryon (MM1) Non-Executive Director Prof. Ghulam Mufti (GM1) Non-Executive Director Sue Slipman (SS) Non-Executive Director Christopher Stooke (CS) Non-Executive Director Tim Smart (TS) Chief Executive Pedro Castro (PC) - Non-voting Director Interim Director of Strategy Angela Huxham (AH) Director of Workforce Development Dr. Michael Marrinan (MM) Medical Director Roland Sinker (RS) Chief Operating Officer Simon Taylor (ST) Chief Financial Officer Dr. Geraldine Walters (GW) Director of Nursing & Midwifery Jane Walters (JW) - Non-voting Director Director of Corporate Affairs In attendance: Prof Reza Razavi (RR) Director of Research, KHP Tamara Cowan (TC) Board Secretary (Minutes) Sally Lingard (SL) Associate Director of Communications Apologies: Circulation to: Board of Directors Circulation List Enclosure Lead Time 1. STANDING ITEMS G Alberti 14:00 1.1. Apologies 1.2. Declarations of Interest 1.3. Chair’s Action 1.4. Minutes of Previous Meeting – 25/02/2014 Enc 1.4 1.5. Matters Arising/Action Tracking Enc 1.5 2. FOR REPORT/DISCUSSION 2.1. KHP Update (Research) Verbal Prof Razavi 14:05 2.2. Chair’s Report to the Board Enc. 2.2 G Alberti 14:25 2.3. Update from Board Committee Chairs 14:35 2.3.1. Audit Committee Verbal C Stooke 2.3.2. Board Integration Committee Verbal C Stooke 2.3.3.
    [Show full text]
  • Lawrence Today, Volume 91, Number 1, Fall 2010 Lawrence University
    Lawrence University Lux Lawrence Today 10-1-2010 Lawrence Today, Volume 91, Number 1, Fall 2010 Lawrence University Follow this and additional works at: http://lux.lawrence.edu/lawrencetoday © Copyright is owned by the author of this document. Recommended Citation Lawrence University, "Lawrence Today, Volume 91, Number 1, Fall 2010" (2010). Lawrence Today. Book 3. http://lux.lawrence.edu/lawrencetoday/3 This Book is brought to you for free and open access by Lux. It has been accepted for inclusion in Lawrence Today by an authorized administrator of Lux. For more information, please contact [email protected]. From the President Dear Lawrentians, Much like the students who graduate from Lawrence University the fore the remarkable achievements of Lawrence University, its each year, this institution, too, is on a path of continuous students and faculty. transformation. The core remains unchanged — an abiding commitment to the ideals of liberal learning — and our mission In 2010, we are very proud that considerable progress has been statement and educational philosophy are the anchors to the made in the past five years and that our work is producing university’s traditions and reason for being, providing guidance to distinguished results. We have significant momentum on our side the administration and faculty as we move into the second decade as we welcome the Class of 2014. of the millennium. Because transformation is an unending process, not a task to be Lawrence today, however, is not your grandfather’s (or grandmother’s) checked off a list when completed, it is safe to say we are eager Lawrence University and it should not be so.
    [Show full text]
  • BOOK REVIEWS Example, That a Red Eye May Be Iritis, but You Can’T Remember What the Assessments
    adrenal surgery is at best contentious. In the second edition of the module books, perhaps the textbook sections could be omitted. The section on investigations and practical procedures is well laid book review s out. Separate discussions of stimulatory and inhibitory tests, nicely promote the central concept of dynamic testing in endocrinology: if high, try to suppress; if low try to stimulate. Medical Masterclass, Royal College of Physicians, Editor-in- The website has to be regarded as experimental. To study on the chief John D Firth. Blackwell Science 2001 web would clock up many hours of connection time; spouses may become agitated at loss of access to the phone. 12 Modules, pp2,200. 2 CD-ROMS including 60 case The best feature of Medical Masterclass , the interactive cases, studies. Companion website: www.medical-masterclass.com could be provided on CD ROMS, reissued from year to year. If this (Reviewed from the perspective of a senior educator) were done, the website could be used to point to seminal papers in Training in internal medicine must be rescued from the crisis the current literature. Different individuals are likely to learn most precipitated by current limits on working time. How may adequate efficiently by different techniques. The website is a brilliant concept experience be gained in the early postgraduate years? The tendency under test. to focus upon ‘education’ as a substitute for training would, if The individual subscription price of £495 appears high, although unchecked, produce a knowledgeable but unskilled generation of if the Masterclass books become widely associated with success in clinicians.
    [Show full text]